Ro_NN
09-2210_CD
exhibits_VBZ
potent_JJ
anti-proliferative_JJ
effects_NNS
on_IN
activated_VBN
T_NN
cells_NNS
by_IN
selectively_RB
blocking_VBG
MKK_NN
activity_NN
._.

By_IN
using_VBG
high_JJ
throughput_NN
screening_NN
of_IN
microbial_JJ
broths_NNS
,_,
we_PRP
have_VBP
identified_VBN
a_DT
compound_NN
,_,
designated_VBN
Ro_NN
09-2210_CD
,_,
which_WDT
is_VBZ
able_JJ
to_TO
block_VB
anti-CD3_NN
induced_JJ
peripheral_JJ
blood_NN
T_NN
cell_NN
activation_NN
with_IN
an_DT
IC50_NN
=_JJ
40_CD
nM_NN
._.

Ro_NN
09-2210_CD
was_VBD
also_RB
able_JJ
to_TO
block_VB
antigen-induced_JJ
IL-2_NN
secretion_NN
with_IN
an_DT
IC50_NN
=_JJ
30_CD
nM_NN
,_,
but_CC
was_VBD
considerably_RB
less_RBR
potent_JJ
at_IN
blocking_VBG
Ca2_NN
+_CC
flux_NN
stimulated_VBN
by_IN
anti-CD3_JJ
treatment_NN
._.

To_TO
determine_VB
the_DT
mechanism_NN
of_IN
action_NN
of_IN
Ro_NN
09-2210_CD
,_,
we_PRP
set_VBD
up_RP
a_DT
transient_JJ
expression_NN
system_NN
in_IN
Jurkat_NN
T_NN
cells_NNS
using_VBG
a_DT
variety_NN
of_IN
reporter_NN
gene_NN
constructs_NNS
and_CC
showed_VBD
effective_JJ
inhibition_NN
of_IN
phorbol_NN
ester\/ionomycin-induced_JJ
NF-AT_NN
activation_NN
and_CC
anti-CD3_JJ
induced_JJ
NF-AT_NN
with_IN
IC50_NN
=_JJ
7.7_CD
and_CC
10_CD
nM_NN
,_,
respectively_RB
._.

Ro_NN
09-2210_CD
was_VBD
also_RB
able_JJ
to_TO
inhibit_VB
phorbol_NN
ester\/ionomycin-induced_JJ
activation_NN
of_IN
AP1_NN
with_IN
IC50_NN
=_VBG
&lt;_JJR
10_CD
nM_NN
._.

We_PRP
further_RB
showed_VBD
that_IN
Ro_NN
09-2210_CD
was_VBD
unable_JJ
to_TO
inhibit_VB
c-jun_NN
induced_VBD
expression_NN
of_IN
AP1-dependent_JJ
reporter_NN
constructs_NNS
-LRB-_-LRB-
IC50_NN
&gt;_JJR
500_CD
nM_NN
-RRB-_-RRB-
,_,
but_CC
was_VBD
able_JJ
to_TO
potently_RB
inhibit_VB
ras-induced_JJ
AP1_NN
activation_NN
-LRB-_-LRB-
IC50_NN
=_JJ
20_CD
nM_NN
-RRB-_-RRB-
._.

This_DT
suggested_VBD
that_IN
Ro_NN
09-2210_CD
was_VBD
inhibiting_VBG
an_DT
activator_NN
of_IN
AP-1_NN
which_WDT
was_VBD
upstream_JJ
of_IN
c-jun_NN
and_CC
downstream_JJ
of_IN
ras_NN
signaling_NN
._.

To_TO
investigate_VB
further_RB
,_,
we_PRP
then_RB
purified_VBD
a_DT
number_NN
of_IN
different_JJ
kinases_NNS
,_,
including_VBG
PKC_NN
,_,
PhK_NN
,_,
ZAP-70_NN
,_,
ERK_NN
,_,
and_CC
MEK_NN
1_CD
-LRB-_-LRB-
a_DT
MKK_NN
-RRB-_-RRB-
,_,
and_CC
showed_VBD
that_IN
Ro_NN
09-2210_CD
was_VBD
a_DT
selective_JJ
inhibitor_NN
of_IN
MEK1_NN
in_FW
vitro_FW
-LRB-_-LRB-
IC50_NN
=_JJ
59_CD
nM_NN
-RRB-_-RRB-
._.

